Transitional cell carcinoma epidemiology and demographics: Difference between revisions
No edit summary |
|||
| Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
Transitional cell carcinoma of the renal pelvis, | *Transitional cell carcinoma of the renal pelvis, accounts for only 7% of all kidney tumors.<ref name= NIH>Transitional cell cancer. National cancer institute. http://www.cancer.gov/types/kidney/hp/transitional-cell-treatment-pdq#section/_1</ref> | ||
*Transitional cell cancer of the ureter, accounts for only 1 of every 25 upper tract tumors. | |||
*They are curable in more than 90% of patients if they are superficial and confined to the renal pelvis or ureter. | |||
*Patients with deeply invasive tumors that are still confined to the renal pelvis or ureter have a 10% to 15% likelihood of cure. | |||
*Patients with tumors with penetration through the urothelial wall or with distant metastases usually cannot be cured with currently available forms of treatment. | |||
==References== | ==References== | ||
Revision as of 16:30, 10 February 2016
|
Transitional cell carcinoma Microchapters |
|
Differentiating Transitional cell carcinoma from other Diseases |
|---|
|
Diagnosis |
|
Treatment |
|
Case Studies |
|
Transitional cell carcinoma epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Transitional cell carcinoma epidemiology and demographics |
|
FDA on Transitional cell carcinoma epidemiology and demographics |
|
CDC on Transitional cell carcinoma epidemiology and demographics |
|
Transitional cell carcinoma epidemiology and demographics in the news |
|
Blogs on Transitional cell carcinoma epidemiology and demographics |
|
Directions to Hospitals Treating Transitional cell carcinoma |
|
Risk calculators and risk factors for Transitional cell carcinoma epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Epidemiology and Demographics
- Transitional cell carcinoma of the renal pelvis, accounts for only 7% of all kidney tumors.[1]
- Transitional cell cancer of the ureter, accounts for only 1 of every 25 upper tract tumors.
- They are curable in more than 90% of patients if they are superficial and confined to the renal pelvis or ureter.
- Patients with deeply invasive tumors that are still confined to the renal pelvis or ureter have a 10% to 15% likelihood of cure.
- Patients with tumors with penetration through the urothelial wall or with distant metastases usually cannot be cured with currently available forms of treatment.
References
- ↑ Transitional cell cancer. National cancer institute. http://www.cancer.gov/types/kidney/hp/transitional-cell-treatment-pdq#section/_1